{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-23T12:20:06.387696+00:00",
  "news": [
    {
      "title": "Is it too late to sell Amgen Inc. - Quarterly Trade Report & High Conviction Investment Ideas - Newser",
      "link": "https://news.google.com/rss/articles/CBMickFVX3lxTE9aMlUxdmoyd3Jianh3X1oycDFwZE93ZFktQk9SeFRfb0ZHVWhlWUZZbzFNeFR3blNvek03YlFGSllOMlQ4RHhkRXU4UkNONlFTWGZoSGM1X040VkxoSjhpQ3VhUFdKR1BUeF94YjUxeDJ4dw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMickFVX3lxTE9aMlUxdmoyd3Jianh3X1oycDFwZE93ZFktQk9SeFRfb0ZHVWhlWUZZbzFNeFR3blNvek03YlFGSllOMlQ4RHhkRXU4UkNONlFTWGZoSGM1X040VkxoSjhpQ3VhUFdKR1BUeF94YjUxeDJ4dw?oc=5\" target=\"_blank\">Is it too late to sell Amgen Inc. - Quarterly Trade Report & High Conviction Investment Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-08-23T03:35:36+00:00",
      "source": "Newser"
    },
    {
      "title": "Korea Investment CORP Trims Stake in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNa1ktYlp5N2FXNk5McF9PblZnOHFVOWhUd2t2dV9PZU5seTNaMTBxSVIyQ1J5dzJrNjV3dnlPYnJlbkxxWHJaaEZfc0tFTDF6TVdEV2h0WlZSeG51M2FtbGFSU0lmRXY0Z3FRU0x5WFh5RzVjZ0R2NFk4Y1dVZGVibzc2dnRfWkxBTVRDaVdPdnFCUVpqV25KWm9nRTlvNHFxbFlBM0xya1FxcC0zVHgwZkRrbGlUdzNy?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNa1ktYlp5N2FXNk5McF9PblZnOHFVOWhUd2t2dV9PZU5seTNaMTBxSVIyQ1J5dzJrNjV3dnlPYnJlbkxxWHJaaEZfc0tFTDF6TVdEV2h0WlZSeG51M2FtbGFSU0lmRXY0Z3FRU0x5WFh5RzVjZ0R2NFk4Y1dVZGVibzc2dnRfWkxBTVRDaVdPdnFCUVpqV25KWm9nRTlvNHFxbFlBM0xya1FxcC0zVHgwZkRrbGlUdzNy?oc=5\" target=\"_blank\">Korea Investment CORP Trims Stake in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-23T07:36:22+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "From Blocking to Locking: Rethinking How Amgen Intervenes in Disease - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTlU1T1JpODczeU91amV6b0dBc0JMbG1iR1hwM3diMl9kdUtvTFVlWUctc1VyZmJWOUdKWWxaSDJzOUtFVWI5amwyeGNNYmpldnFBdndJdFVwRXUxOGFoMzZyTDBTRW5tSlZ6WEIzUjZMdUhJZ3lJbm5Ua0psRnFiMC1wTV9namRHanVrbF9hVDh4dm8zaVhMelg1ZHJyejBkTjB0WWkxZ252U28?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTlU1T1JpODczeU91amV6b0dBc0JMbG1iR1hwM3diMl9kdUtvTFVlWUctc1VyZmJWOUdKWWxaSDJzOUtFVWI5amwyeGNNYmpldnFBdndJdFVwRXUxOGFoMzZyTDBTRW5tSlZ6WEIzUjZMdUhJZ3lJbm5Ua0psRnFiMC1wTV9namRHanVrbF9hVDh4dm8zaVhMelg1ZHJyejBkTjB0WWkxZ252U28?oc=5\" target=\"_blank\">From Blocking to Locking: Rethinking How Amgen Intervenes in Disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-08-21T18:50:33+00:00",
      "source": "Amgen"
    },
    {
      "title": "Stock Analysis | Amgen Outlook - Mixed Signals Amid Strong Fundamentals - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPOGhET1gySHB4Sml0cE5hQ1o5dGFFQ1BZT282RmFaLTlqQV9IQ3BfT3VnR3NzZXN0YUI3V1BNSDlZZnluLVMxTEpYZjkzTnN0WUxzcUY1c2l0R3pCdDVqV0QwSXhRNDhtZXUwT3hHbnF0ZklwXzFjdVFkY3hNNkZDZFNWVnd3UUxVV3Q2NUgzdm0wNGF6N2FNeHJxa1ZEWTBhOUE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxPOGhET1gySHB4Sml0cE5hQ1o5dGFFQ1BZT282RmFaLTlqQV9IQ3BfT3VnR3NzZXN0YUI3V1BNSDlZZnluLVMxTEpYZjkzTnN0WUxzcUY1c2l0R3pCdDVqV0QwSXhRNDhtZXUwT3hHbnF0ZklwXzFjdVFkY3hNNkZDZFNWVnd3UUxVV3Q2NUgzdm0wNGF6N2FNeHJxa1ZEWTBhOUE?oc=5\" target=\"_blank\">Stock Analysis | Amgen Outlook - Mixed Signals Amid Strong Fundamentals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-23T06:53:44+00:00",
      "source": "AInvest"
    },
    {
      "title": "How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com",
      "link": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNRlFnU1VpVDBreF9SVFdhdEhSclZXb1ZrRE1jSWVtSTRQVkcwMWtpMlFzS3NqRGZzUERBSEs0YW91T2xRbWtHZUx3VUFRdkJOOEJJODZDV1FFREFaOEhjVmRtNGhMN1RZZWtpckZQanN3cm1qUVNTR1M3NEM3dnFHMWR1VjhoRzZwdHQxeHdQaU5VaTh6Zm9JWml5SUE5b2gwV0NEVW01UTQwQXFHWWlpSVJEWXdJOVhVMlJlNUdXSGpwcl9SdXFZeERQMFV5OEE5?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNRlFnU1VpVDBreF9SVFdhdEhSclZXb1ZrRE1jSWVtSTRQVkcwMWtpMlFzS3NqRGZzUERBSEs0YW91T2xRbWtHZUx3VUFRdkJOOEJJODZDV1FFREFaOEhjVmRtNGhMN1RZZWtpckZQanN3cm1qUVNTR1M3NEM3dnFHMWR1VjhoRzZwdHQxeHdQaU5VaTh6Zm9JWml5SUE5b2gwV0NEVW01UTQwQXFHWWlpSVJEWXdJOVhVMlJlNUdXSGpwcl9SdXFZeERQMFV5OEE5?oc=5\" target=\"_blank\">How Amgen Inc. (AMGN) Affects Rotational Strategy Timing</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">news.stocktradersdaily.com</font>",
      "published": "2025-08-23T07:42:02+00:00",
      "source": "news.stocktradersdaily.com"
    },
    {
      "title": "Amgen and AstraZeneca Launch Promising Phase 3 Lung Cancer Study - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPdGY5bWpMajhvZ2pUbDBtZGEzWTFJNW44S01aaU8xNXRuUVRSUXkzWDFFdGhWeWZ5b05aZWpiNlkza0FjakpJaVNlRE9BXzZnSHcyR2ZfcVltNE16M25lTnluZWVoYm9wUjM5QjhKSzRwNVI3TDZTQXUwNWE0bEgyX1BWam9hV2FIY0c0M3dyMldyejdWbmpLZEhiWE8zcU5EcHVpR1Zub1FRZjlxZEU4RU0xdTl6TE0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxPdGY5bWpMajhvZ2pUbDBtZGEzWTFJNW44S01aaU8xNXRuUVRSUXkzWDFFdGhWeWZ5b05aZWpiNlkza0FjakpJaVNlRE9BXzZnSHcyR2ZfcVltNE16M25lTnluZWVoYm9wUjM5QjhKSzRwNVI3TDZTQXUwNWE0bEgyX1BWam9hV2FIY0c0M3dyMldyejdWbmpLZEhiWE8zcU5EcHVpR1Zub1FRZjlxZEU4RU0xdTl6TE0?oc=5\" target=\"_blank\">Amgen and AstraZeneca Launch Promising Phase 3 Lung Cancer Study</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-22T16:24:22+00:00",
      "source": "TipRanks"
    },
    {
      "title": "SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE95Z1pmMU56eWhNSV8ySUcyZWN4S0J0OXNiYUlNWTNpNVBDMkFRY042ODhtXzZHeFJPbGlVdjd6SFZ5U2Z3WVEwcURFa21jSGV0UmZGWlZBLUUtUmR1ck9tRUpOTk9CemNpZHV0ZEJWNjFNV0o0cjJOa0xOOWQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTE95Z1pmMU56eWhNSV8ySUcyZWN4S0J0OXNiYUlNWTNpNVBDMkFRY042ODhtXzZHeFJPbGlVdjd6SFZ5U2Z3WVEwcURFa21jSGV0UmZGWlZBLUUtUmR1ck9tRUpOTk9CemNpZHV0ZEJWNjFNV0o0cjJOa0xOOWQ?oc=5\" target=\"_blank\">SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-21T09:38:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen's ChemoCentryx prevails in investor lawsuit centered on autoimmune drug Tavneos - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQQ1hDaEdTYW9QNHhXZElVLTctaTJKMWNfSzJ1dUl6ZXlSZUF0Q1JoNnNpT0tRM2NVN2xPUkpDSXp0elozalN4ODRWWUhIS3oyNWRQeHFLQW9DVmtRWmNwTjFQZDNISWJWNVFtLWppeEhFU3FJMDQtTTU1ZGhCRktXc0t4ak0xTU9lVV9FYzlHTzJVZ1VLV2kzS1cxdi1hc1AtZjl6TjJZZDVGMG9JUnBhbEZR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQQ1hDaEdTYW9QNHhXZElVLTctaTJKMWNfSzJ1dUl6ZXlSZUF0Q1JoNnNpT0tRM2NVN2xPUkpDSXp0elozalN4ODRWWUhIS3oyNWRQeHFLQW9DVmtRWmNwTjFQZDNISWJWNVFtLWppeEhFU3FJMDQtTTU1ZGhCRktXc0t4ak0xTU9lVV9FYzlHTzJVZ1VLV2kzS1cxdi1hc1AtZjl6TjJZZDVGMG9JUnBhbEZR?oc=5\" target=\"_blank\">Amgen's ChemoCentryx prevails in investor lawsuit centered on autoimmune drug Tavneos</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-19T14:13:25+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "UK court clears the way for Amgen and Samsung to launch biosimilars - Life Sciences Intellectual Property Review",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5\" target=\"_blank\">UK court clears the way for Amgen and Samsung to launch biosimilars</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Life Sciences Intellectual Property Review</font>",
      "published": "2025-05-22T07:00:00+00:00",
      "source": "Life Sciences Intellectual Property Review"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-22",
      "close": 293.7200012207031
    },
    "history": [
      {
        "date": "2025-08-14",
        "close": 287.95404052734375
      },
      {
        "date": "2025-08-15",
        "close": 294.08428955078125
      },
      {
        "date": "2025-08-18",
        "close": 290.2652587890625
      },
      {
        "date": "2025-08-19",
        "close": 293.17169189453125
      },
      {
        "date": "2025-08-20",
        "close": 294.064453125
      },
      {
        "date": "2025-08-21",
        "close": 293.3800048828125
      },
      {
        "date": "2025-08-22",
        "close": 293.7200012207031
      }
    ],
    "name": "Amgen Inc."
  }
}